Bitcoin posts 15% weekly gain amid broader crypto rally: CNBC Crypto World

Bitcoin posts 15% weekly gain amid broader crypto rally: CNBC Crypto World


Share

CNBC Crypto World features the latest news and daily trading updates from the digital currency markets and provides viewers with a look at what’s ahead with high-profile interviews, explainers, and unique stories from the ever-changing crypto industry. On today’s show, Crypto World explores how blockchain analytics firms partner with the private and public sectors to track down stolen funds.



Source

Chinese EV maker Xpeng to launch robotaxis, humanoid robots with self-developed AI chips
World

Chinese EV maker Xpeng to launch robotaxis, humanoid robots with self-developed AI chips

Chinese EV company Xpeng showed off its newest humanoid robot in Guangzhou on Nov. 5, 2025. CNBC | Evelyn Cheng Guangzhou, CHINA — Chinese electric car company Xpeng plans to launch robotaxis next year after previously claiming it wouldn’t be a real business in the near future and took the wraps off of its latest […]

Read More
Asia’s private equity funds turn bullish on China, betting on Beijing’s tech-focused economic plan
World

Asia’s private equity funds turn bullish on China, betting on Beijing’s tech-focused economic plan

Zhang Lei, founder and chairman of Hillhouse Investment, during the Global Financial Leaders’ Investment Summit in Hong Kong, China, on Wednesday, Nov. 5, 2025. Bloomberg | Getty Images Asia-focused private equity managers are turning more bullish on the world’s second-largest economy, betting on Beijing’s drive for technological self-sufficiency and rapid adoption to deliver the next […]

Read More
Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount
World

Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount

A box of Ozempic sits on a table in North Tyneside, Britain, Oct. 31, 2023. Lee Smith | Reuters Danish pharmaceutical giant Novo Nordisk said Wednesday it is trimming its growth expectations for its leading obesity and diabetes treatments as competition intensifies and pricing pressures mount in the weight loss market. Net profit for the […]

Read More